Alkem Labs Q3 net profit rises 14% to Rs 205.45 cr

PTI New Delhi | Updated on February 08, 2019 Published on February 08, 2019

Drug firm Alkem Laboratories on Friday reported a 13.58 per cent rise in its consolidated net profit to Rs 205.45 crore for the quarter ended December 31, 2018.

The company had posted a net profit of Rs 180.87 crore for the corresponding period of the previous fiscal, Alkem Laboratories said in a filing to BSE.

Consolidated revenue from operations of the company stood at Rs 1,925.03 crore for the quarter under consideration as against Rs 1,741.19 crore for the same period a year ago.

The company’s board has declared an interim dividend of Rs 8 per equity share of the face value of 2 each, Alkem Laboratories said.

Shares of the company were trading at Rs 1,893.50 per scrip on BSE, up 0.57 per cent from its previous close.

Follow us on Telegram, Facebook, Twitter Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on February 08, 2019
This article is closed for comments.
Please Email the Editor